✦ LIBER ✦

Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients

✍ Scribed by Marcus Valadão; Danielle Braggio; Anna Flávia Santos; Haynna Kimie Pimenta-Inada; Eduardo Linhares; Rinaldo Gonçalves; Sérgio Romano; Bruno Vilhena; Isabele Small; Daniel Cubero; Felipe Cruz; Antônio Talvane Oliveira; Olga Martinho; Rui Manuel Reis; Denise Peixoto Guimarães; Carlos Gil Ferreira

Book ID: 118481443
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 772 KB
Volume: 178
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2012.03.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

386 Effect of angio-sonography to monito

386 Effect of angio-sonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumor (GIST): a preliminary report

✍ U. De Giorgi; C. Aliberti; G. Benea; M. Conti; M. Marangolo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Response to Imatinib Rechallenge of GIST

Response to Imatinib Rechallenge of GIST That Recurs Following Completion of Adjuvant Imatinib Treatment - the First Analysis in the SSGXVIII/AIO Trial Patient Population

✍ P. Reichardt; J.T Hartmann; K. Sundby Hall; M. Eriksson; J. Schütte; G. Ramadori 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Predictive factors for long-term effects

Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)

✍ Piotr Rutkowski; Zbigniew I. Nowecki; Maria Dębiec-Rychter; Urszula Grzesiakowsk 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 489 KB

Prediction of response to treatment with

Prediction of response to treatment with phenelzine in neurotic patients

✍ Mountjoy, Christopher Q.; Marshall, Elizabeth F.; Campbell, Iain C.; Garside, Ro 📂 Article 📅 1980 🏛 Elsevier Science ⚖ 420 KB

Resection of residual disease in patient

Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib

✍ Sebastian Bauer; Jörg Thomas Hartmann; Maike de Wit; Hauke Lang; Florian Grabell 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 723 KB

## Abstract Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. Long‐term survival of patients with metastatic disease has only been observed in patients with completely resected disease. Recently, the tyrosine kinase inhibitor imatinib has b

Patterns of Care, Prognosis, and Surviva

Patterns of Care, Prognosis, and Survival in Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Refractory to First-Line Imatinib and Second-Line Sunitinib

✍ Antoine Italiano; Angela Cioffi; Paola Coco; Robert G. Maki; Patrick Schöffski; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 384 KB